Your browser doesn't support javascript.
loading
Feedback activation of STAT3 mediates trastuzumab resistance via upregulation of MUC1 and MUC4 expression.
Li, Guangchao; Zhao, Likun; Li, Wei; Fan, Kexing; Qian, Weizhu; Hou, Sheng; Wang, Hao; Dai, Jianxin; Wei, Huafeng; Guo, Yajun.
Afiliação
  • Li G; School of Bioscience and Bioengneering, South China University of Technology, Guangzhou, China.
  • Zhao L; School of Bioscience and Bioengneering, South China University of Technology, Guangzhou, China.
  • Li W; International Joint Cancer Institute, Second Military Medical University, Shanghai, China. School of Pharmacy, Liaocheng University, Liaocheng, Shandong Provence, China.
  • Fan K; International Joint Cancer Institute, Second Military Medical University, Shanghai, China. School of Pharmacy, Liaocheng University, Liaocheng, Shandong Provence, China.
  • Qian W; State Key Laboratory of Antibody Medicine & Targeting Therapy and Shanghai Key Laboratory of Cell Engineering & Antibody, Shanghai, China.
  • Hou S; International Joint Cancer Institute, Second Military Medical University, Shanghai, China. State Key Laboratory of Antibody Medicine & Targeting Therapy and Shanghai Key Laboratory of Cell Engineering & Antibody, Shanghai, China. School of Pharmacy, Liaocheng University, Liaocheng, Shandong
  • Wang H; International Joint Cancer Institute, Second Military Medical University, Shanghai, China. State Key Laboratory of Antibody Medicine & Targeting Therapy and Shanghai Key Laboratory of Cell Engineering & Antibody, Shanghai, China. School of Pharmacy, Liaocheng University, Liaocheng, Shandong
  • Dai J; International Joint Cancer Institute, Second Military Medical University, Shanghai, China. State Key Laboratory of Antibody Medicine & Targeting Therapy and Shanghai Key Laboratory of Cell Engineering & Antibody, Shanghai, China. School of Pharmacy, Liaocheng University, Liaocheng, Shandong
  • Wei H; International Joint Cancer Institute, Second Military Medical University, Shanghai, China. State Key Laboratory of Antibody Medicine & Targeting Therapy and Shanghai Key Laboratory of Cell Engineering & Antibody, Shanghai, China. School of Pharmacy, Liaocheng University, Liaocheng, Shandong
  • Guo Y; School of Bioscience and Bioengneering, South China University of Technology, Guangzhou, China. International Joint Cancer Institute, Second Military Medical University, Shanghai, China. State Key Laboratory of Antibody Medicine & Targeting Therapy and Shanghai Key Laboratory of Cell Engineering
Oncotarget ; 5(18): 8317-29, 2014 Sep 30.
Article em En | MEDLINE | ID: mdl-25327561
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias da Mama / Mucina-1 / Resistencia a Medicamentos Antineoplásicos / Fator de Transcrição STAT3 / Mucina-4 / Anticorpos Monoclonais Humanizados / Antineoplásicos Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Neoplasias da Mama / Mucina-1 / Resistencia a Medicamentos Antineoplásicos / Fator de Transcrição STAT3 / Mucina-4 / Anticorpos Monoclonais Humanizados / Antineoplásicos Idioma: En Ano de publicação: 2014 Tipo de documento: Article